Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

MiMedx wins Australian regulatory nod

September 7, 2018 By Danielle Kirsh

MiMedxMiMedx (Marietta, Ga.) recently received regulatory approval from the Therapeutics Goods Administration in Australia to market its dehydrated Human Amnion/Chorion Membrane products. The approval includes the company’s EpiFix, AmnioFix, EpiBurn, AmnioFix Injectable and AmnioFix Wrap.

MiMedx’s product line approval allows the company to market, distribute and sell its products to physicians to help treat patients with wound care, surgery, sports medicine and pain management.

“This regulatory approval in Australia marks another commercial milestone for MiMedx as we continue to expand our global footprint,” Christopher Cashman, executive VP and chief commercialization officer at MiMedx, said in a press release. “The approval of our EpiFix and AmnioFix product lines by the TGA is an important step in ensuring that Australian patients are able to gain access to innovative products in a timely manner. We look forward to formally launching our products in that market.”

AmnioFix and EpiFix grafts are now able to be marketed for the treatment of acute and chronic wounds to enhance healing. AmnioFix Sports Med and AmnioFix Injectable were both approved to be used for the treatment of chronic plantar fasciitis.

“As a prerequisite to the approval process, MiMedx received a Certificate of Good Manufacturing Practice Compliance from the TGA, indicating that all of our sites comply with the requirements of the Australian Code of GMP for human tissue products,” Cashman said. “This is similar to the GMP requirements in the United States, and further validates the quality of our processing and manufacturing systems and procedures.”

MiMedx has also recently partnered with LifeHealthcare Group to enter the Australian market.

“We have been building our international presence over the last several years. Given the complexity of the regulatory process for human tissue in certain regions outside the U.S., it can take years to get through the regulatory approval and reimbursement process,” John Harris, senior VP of international at MiMedx, said. “We receive regular and strong interest from clinicians and caregivers in numbers international regions, and we remain committed to our long-term strategy of building a presence for MiMedx products outside of the U.S.”

Related Articles Read More >

Galien Foundation 2022 nominees
18 of the world’s most innovative medical technologies
Ariste Medical co-founder Lisa Jennings
Ariste Medical co-founder sees great potential for drug-coated implants and orthopedics
CES-logo-new
CES 2022: Medical technologies you need to know
Cytena's C.Station platform
BICO’s Cytena launches C.Station automated cell line development platform for antibody and gene therapies

DeviceTalks Weekly.

June 24, 2022
How innovative design, commercial strategy is building Cala Trio’s bioelectronic medicine market
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media LLC. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech